Deep Genomics is a biotechnology company that uses artificial intelligence and machine learning to develop genetic medicines. The company's platform combines genomic data with machine learning algorithms to identify and develop therapies for genetic diseases. Deep Genomics is focused on developing treatments for rare genetic diseases, including inherited retinal diseases, lysosomal storage disorders, and neurodegenerative diseases. The company was founded in 2014 and is headquartered in Toronto, Canada.